95 results
424B2
PLSE
Pulse Biosciences Inc
4 Jun 24
Prospectus for primary offering
4:05pm
, California. Of these employees, half were engaged in research and development activities and half were engaged in operations, marketing, business
POS AM
PLSE
Pulse Biosciences Inc
28 May 24
Prospectus update (post-effective amendment)
5:19pm
. Of these employees, half were engaged in research and development activities and half were engaged in operations, marketing, business development
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
7 May 24
Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results
4:14pm
Catheter.”
First Quarter 2024 Financial Results
Total GAAP costs and expenses, representing research and development and general and administrative … by an increase in research and development expenses to support the development of the CellFX nsPFA product portfolio. Non-GAAP costs and expenses
8-K
EX-99.1
am31mf
28 Mar 24
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
4:18pm
8-K
EX-99.1
gy5y3675z32ime5gygwg
13 Nov 23
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
9:12am
8-K
EX-99.1
fdmwrrptymv7gr5jqc
10 Aug 23
Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
ajq1t 247a957xomlx
11 May 23
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
4:15pm